Serial Number 79301302
Registration 6592425
700

Registration Progress

Application Filed
Aug 26, 2020
Under Examination
Approved for Publication
Oct 5, 2021
Published for Opposition
Oct 5, 2021
Registered
Dec 21, 2021

Trademark Image

Basic Information

Serial Number
79301302
Registration Number
6592425
Filing Date
August 26, 2020
Registration Date
December 21, 2021
Published for Opposition
October 5, 2021
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 21, 2021
Registration
Registered
Classes
005 010

Rights Holder

Telix Pharmaceuticals Limited

99
Address
Suite 401,
55 Flemington Road North Melbourne VIC 3
AU

Ownership History

Telix Pharmaceuticals Limited

Original Applicant
99
AU

Telix Pharmaceuticals Limited

Owner at Publication
99
AU

Telix Pharmaceuticals Limited

Original Registrant
99
AU

Legal Representation

Attorney
Andrew S. Ehard

USPTO Deadlines

Next Deadline
728 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20211221)
Due Date
December 21, 2027
Grace Period Ends
June 21, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Aug 14, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jun 27, 2022 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jun 7, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jun 7, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Mar 21, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Dec 21, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 5, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 5, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 15, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 31, 2021 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 31, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 25, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 25, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 25, 2021 ALIE A ASSIGNED TO LIE Loading...
Aug 24, 2021 NREV O NOTICE OF REVIVAL - MAILED Loading...
Aug 23, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 23, 2021 PETG O PETITION TO REVIVE-GRANTED Loading...
Aug 23, 2021 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Aug 16, 2021 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Aug 16, 2021 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Feb 21, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Feb 2, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 2, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jan 19, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 15, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jan 14, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 14, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 14, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 13, 2021 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Dec 31, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; radiopharmaceutical diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use; radiopharmaceutical diagnostic kits consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringes
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a half-circle design consisting of 20 curved lines which extend from the bottom left of the mark to the middle right of the circle design.

Classification

International Classes
005 010